Share on Facebook
Share on Twitter
Share on LinkedIn

The FDA has updated its list of blood pressure medications that are being recalled after traces of a cancer-causing ingredient were found in several batches.

The agency last month said it was recalling valsartan tablets made in China after tests showed some contained Nitrosodimethylamine, or NDMA,  a probable carcinogen.

Read More